Retina Care Specialists | Palm Beach Gardens, FL

Research site

(Unclaimed)

Location

3399 PGA Boulevard, Suite 350, Palm Beach Gardens, Florida, United States of America

Site insights

Top conditions

Top treatments

Lampalizumab

Ranibizumab

MK-8748

Faricimab

OCS-01

EYP-1901

Zimura

MK-8748-004

ranibizumab

Avacincaptad pegol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 22 total trials

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Active, not recruiting

Wet Age Related Macular Degeneration

wAMD

Drug: Aflibercept (2.0 mg)

Drug: EYP-1901

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) (MALBEC)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling

Choroidal Neovascularization

Age-Related Macular Degeneration

Drug: Tiespectus

Drug: Aflibercept

Locations recently updated

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-87...

Enrolling

Macular Edema

Diabetic Retinopathy

Drug: MK-8748

Drug: Aflibercept

Locations recently updated

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy (SIENNA)

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atroph...

Enrolling

Age-related Macular Degeneration (AMD)

Geographic Atrophy (GA)

Drug: Placebo

Drug: Pozelimab

Extension Study for the Port Delivery System With Ranibizumab (Portal)

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with ne...

Enrolling

Neovascular Age-Related Macular Degeneration

Drug: PDS Implant with Ranibizumab 100 mg/mL